Plasma-activated medium induces apoptosis of oral squamous cell carcinoma through the MAPKs pathway
Hun Jang1, Yoon-Seo Jang1, Gyoo-Cheon Kim2,3
1Department of Oral and Maxillofacial Surgery, Dental and Life Science Institute, Dental school, Pusan National University, Yangsan, 50612, Republic of Korea.
Abstract:
No-ozone cold plasma (NCP) is actively being researched as an alternative to address various side effects of cancer treatment. Compared to traditional direct procedures, the indirect method using plasma-activated medium (PAM) has advantages like greater tissue penetration and convenience. The purpose of this study is to assess the efficacy of plasma-activated medium on oral squamous cell carcinoma both in vitro and in vivo. Squamous Cell Carcinoma cells (SCC-25) and human keratinocyte cells (HaCaT) were used in this experiment. The evaluation of cell viability was conducted through sulforhodamine B (SRB) analysis. The effect of PAM was observed on the cytoskeletal structure through F-actin staining. To analyze cell selectivity, immunofluorescence staining was conducted to monitor alterations in the intracellular localization of cytochrome C and AIF. Western blotting was carried out to investigate the mechanism of apoptosis induced by PAM. Mitochondrial intrinsic pathway-related factors, cleaved caspase 3, PARP, Bax and bcl-2 were quantified. The MAPKs-related factors, JNK and pJNK, as well as pERK, ERK, and p38, pp38, were also quantified. Animal experiments were conducted to validate factors verified in vitro for their reproducibility in vivo. To induce tumor formation, SCC-25 cells were injected into nude mice xenograft model and then divided into three groups (CON(-)/CON(+)/PAM) for a 4-week experiment, and the treatment was performed three times per week. Tumor volume and mouse weight were measured, and at the end of the 4-week experiment, tumors were excised and weighed. Tumor tissues were processed for histological analysis, including H&E staining for morphology and TUNEL staining for apoptosis. PAM significantly decreased the viability of SCC-25 cells. F-actin staining showed that PAM disrupted the fibrous structure of SCC-25 cells and reduced the number of cells. Immunofluorescence staining revealed that cytochrome C and AIF, normally present in the mitochondria of normal cells, translocated to the cell nucleus or cytoplasm after PAM treatment. Western blot analysis showed cleaved forms of PARP and caspase 3, factors associated with the intrinsic pathway of apoptosis, and an increase in Bax over time, while bcl-2 decreased. The MAPKs-related factors, JNK and p38, showed increased phosphorylation, whereas ERK phosphorylation decreased. In animal experiments, tumor volume decreased by 32% compared to the control group when treated with PAM, and tumor weight also decreased by 25%. No significant changes were observed in the overall weight of the mice. H&E staining revealed significant morphological changes in tumor tissues following PAM treatment, accompanied by extensive apoptosis, with TUNEL-positive cells markedly increased to 75% compared to 30-42% in controls. 1. PAM can overcome the shortcomings of direct treatment (DT), such as limited tissue penetration and inconveniences of storage and use. 2. PAM exhibits selective cytotoxicity toward oral squamous cell carcinoma cells while preserving viabilityof human keratinocyte cells, suggesting partial cell selectivity. 3. PAM is presumed to induce apoptosis in oral squamous cell carcinoma through the mitochondrial-related intrinsic pathway via MAPK signaling. However, further validation using pathway inhibition studies is needed to confirm this mechanism.
Insights
Plasma-activated medium (PAM) effectively reduced oral cancer cell viability and tumor growth in vivo. This cancer treatment alternative induces apoptosis through the mitochondrial pathway, offering potential advantages over direct plasma application.
Area of Science:
- Biomedical Engineering
- Oncology
- Plasma Physics
Background:
- No-ozone cold plasma (NCP) is explored for cancer treatment, with plasma-activated medium (PAM) offering improved tissue penetration and convenience over direct methods.
- Oral squamous cell carcinoma (OSCC) presents challenges in treatment, necessitating novel therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy and underlying mechanisms of plasma-activated medium (PAM) against oral squamous cell carcinoma (OSCC) in vitro and in vivo.
- To assess PAM's selectivity towards cancer cells compared to normal keratinocytes.
Main Methods:
- In vitro studies utilized SCC-25 (OSCC) and HaCaT (keratinocyte) cells, assessing viability (SRB), cytoskeletal changes (F-actin), apoptosis markers (cytochrome C, AIF, Western blot for cleaved caspase 3, PARP, Bax, bcl-2), and MAPK signaling (JNK, p38, ERK).
- In vivo studies involved an SCC-25 xenograft nude mouse model treated with PAM, monitoring tumor volume, weight, and performing histological analyses (H&E, TUNEL).
Main Results:
- PAM significantly reduced SCC-25 cell viability, disrupted F-actin cytoskeleton, and induced apoptosis by promoting mitochondrial translocation of cytochrome C and AIF.
- Western blot confirmed PAM-induced apoptosis via the intrinsic pathway (cleaved PARP/caspase 3, altered Bax/bcl-2 ratios) and modulated MAPK signaling (increased JNK/p38 phosphorylation, decreased ERK phosphorylation).
- In vivo, PAM treatment decreased tumor volume by 32% and tumor weight by 25% without affecting mouse weight, with significant increases in tumor cell apoptosis (TUNEL assay).
Conclusions:
- Plasma-activated medium demonstrates selective cytotoxicity against oral squamous cell carcinoma cells, inducing apoptosis through the mitochondrial intrinsic pathway and MAPK signaling.
- PAM offers a promising alternative to direct plasma treatment for OSCC, overcoming limitations like tissue penetration and handling.
- Further studies involving pathway inhibition are recommended to fully elucidate the apoptotic mechanisms induced by PAM.
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway
Apoptosis
Induced Pluripotent Stem Cells
Somatic...


